Real response to therapy in chronic hepatitis C virus patients: a study from iran. - Wikidata - awgldk - TriplyDB

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

http://www.wikidata.org/entity/Q36329140

about

Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis Epidemiology of hepatitis C virus in Iran Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline Treatment outcome in chronic hepatitis C infection: a four years survey among Iranian patients.Evaluated outcomes in patients with Chronic Hepatitis C.Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network.Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus.Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C.Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients.Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.Some considerations about cardiac toxicity of combination therapy for chronic hepatitis C.

P2860

Q26747679-97F0C439-9651-4FA1-B7AF-DC81CC796DDA Q26781996-2CA83DB0-3EED-4319-B3BF-6C754014710D Q28076883-19B6162E-1D80-40F8-A8DC-2F831080BC20 Q33422617-F6CD22A4-A42B-4206-907D-2F51DC675A7A Q33596752-09D97418-1BAA-417F-89F5-BC91C718F91D Q33808119-D4B0CAF4-5185-45F7-BAFD-7AE347F75331 Q35025269-A922A2B2-0271-4209-AF2F-752DC0E45004 Q35925546-D9835BE9-440A-4944-BBE2-1E9F6B1841D3 Q36182539-29B0B2EB-2BBF-4954-BC17-50BA7E84DD86 Q37138784-ADEA6BCB-7E73-4EEB-97BC-BBB2892CB53B Q37228722-374A502A-7B75-41FB-ABD2-70A2AD5F5503 Q40514319-A0A11007-2BAC-415A-8CE0-2A701C4AEEC7 Q42199023-C76ECF1B-AEBD-49C9-9046-14D1A76BDB30 Q42215059-40CD113E-27B9-412B-8A26-5D870A149617 Q42552240-B1D4A9A9-88DB-423E-9496-01163B7A1ECF

P2860

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

http://www.wikidata.org/entity/Q36329140

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

@ast

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

@en

type

label

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

@ast

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

@en

prefLabel

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

@ast

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

@en

P1433

Q36329140-F5985530-3BE8-4D7C-9144-2FFF9BFF438C

P1476

Q36329140-03B5117C-D073-41E7-AD84-90CB1DF481A2

P2093

Q36329140-4B61EAF7-2BE6-437D-B291-A60BCD3B2D63

Q36329140-570AF080-88EE-4A7C-882C-CEF6C0A00C4F

Q36329140-EAB0F85C-8007-400A-A126-C8BDA3CACF8A

Q36329140-EF9AA774-92CB-4222-AF61-4272909E3C2A

P2860

Q36329140-08F77C4E-0ABD-4609-B918-08C0F17588A5

Q36329140-15D1AE98-1D2B-4D8A-AFA2-547F56B10713

Q36329140-29555458-2D35-45B8-AD97-2EE6401B8FC0

Q36329140-2CEBE93D-8502-4020-8CF8-53202539261F

Q36329140-2D55ECA0-881D-4411-9F5A-0560682115A5

Q36329140-407291D7-18FF-43BB-B876-29A12610856B

Q36329140-4715F16C-6871-4638-9C99-ABCBD68B2A92

Q36329140-50584BD5-7363-4DB6-9B81-350A52992262

Q36329140-5A21320B-0E8A-42A8-B617-285E6A9709CF

Q36329140-5A4AA74B-8AFA-4D31-AECE-AE9AD92B78AE

P304

Q36329140-AE97F999-CF25-4280-8899-12392EFB3538

P31

Q36329140-F44A7B7E-57B5-45F6-85A1-562A0C79BBC5

P356

Q36329140-2AFDC699-24AB-4B5F-A0F6-4E2995F95021

P407

Q36329140-9954BB3E-A91A-44CC-874E-EE29FE757DE3

P433

Q36329140-B36DE659-6E02-4683-9F44-3D3A353EFD32

P478

Q36329140-602A48E3-89E1-41E8-9AB9-672F083AFFCE

P50

Q36329140-9684CC84-67BE-47FA-8E3E-AFBE8BD3D7FF

Q36329140-C6BFB8F7-2F99-4D96-8599-016E9E09BA51

P577

Q36329140-0FB4ECC9-F358-4DE4-9299-002546F4920E

P5875

Q36329140-5ABEAC02-8927-40E4-B9A0-970753CBEAD3

P698

Q36329140-597E4EBA-D156-46C9-92CE-2320B19BF13B

P932

Q36329140-6AA3B479-D2C3-4E6B-82C0-5F0CA1B35A92

P356

P1433

Hepatitis Monthly

P1476

Real response to therapy in chronic hepatitis C virus patients: a study from iran

@en

P2093

Bita Behnava

http://www.w3.org/2001/XMLSchema#string

Mostafa Shafiei

http://www.w3.org/2001/XMLSchema#string

Najmeh Namazee

http://www.w3.org/2001/XMLSchema#string

Sorour Asadi

http://www.w3.org/2001/XMLSchema#string

P2860

A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients

Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment

Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.

Pegaferon in hepatitis C: Results of a Multicenter Study

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

P304

e6151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/HEPATMON.6151

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Seyed Moayed Alavian

P577

2012-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232536447

http://www.w3.org/2001/XMLSchema#string

P698

23087759

http://www.w3.org/2001/XMLSchema#string

P932

3475060

http://www.w3.org/2001/XMLSchema#string